Lv1
36 积分 2023-08-29 加入
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
2天前
已完结
Immune responses in checkpoint myocarditis across heart, blood and tumour
4天前
已完结
Cytokine-mediated CAR T therapy resistance in AML
28天前
已完结
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
3个月前
已完结
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
3个月前
已完结
Multivalent, asymmetric IL-2–Fc fusions show enhanced selectivity for regulatory T cells
3个月前
已完结
Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer
3个月前
已完结
Machine learning-aided generative molecular design
4个月前
已完结
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors
4个月前
已完结
Targeting replication stress in cancer therapy
4个月前
已完结
皖公网安备34019202002308
